| Chronic Lymphocytic Leukemia |
1 |
1 |
| Biologic Therapy |
0 |
0.95 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.64 |
| Healthcare and Medical Technology |
0 |
0.56 |
| Otolaryngology |
0 |
0.56 |
| Cancer |
0 |
0.45 |
| Clinical Research |
0 |
0.45 |
| Targeted Cancer Therapy |
0 |
0.39 |
| Blood |
0 |
0.37 |
| Prophylaxis |
0 |
0.37 |
| Fungal Infection |
0 |
0.32 |
| Microbicides |
0 |
0.3 |
| B-Cell Lymphoma |
0 |
0.26 |
| CNS Lymphoma |
0 |
0.24 |
| Primary CNS Lymphoma |
0 |
0.24 |
| Lymphoma |
0 |
0.22 |
| Cytomegalovirus |
0 |
0.15 |
| Hematology |
0 |
0.15 |
| Hospital |
0 |
0.15 |
| Neutrophils |
0 |
0.15 |
| Interleukin-2 |
0 |
0.1 |
| Antibiotics |
0 |
0.09 |
| Herpes Simplex |
0 |
0.09 |
| Neuroendocrine Tumor |
0 |
0.09 |
| Neutropenia |
0 |
0.09 |
| Pneumonia |
0 |
0.09 |
| Antifungal |
0 |
0.07 |
| Antiviral Agents |
0 |
0.07 |
| Bronchoscopy |
0 |
0.07 |
| Central Nervous System |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Hypogammaglobulinemia |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Leukemia |
0 |
0.07 |
| Natural Killer (NK) Cells |
0 |
0.07 |
| Scholarship |
0 |
0.07 |
| Splenectomy |
0 |
0.07 |